Mexico - Delayed Quote MXN
Beam Therapeutics Inc. (BEAM.MX)
390.00
+15.65
+(4.18%)
At close: April 10 at 12:01:09 PM CST
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-347,246
-347,246
-149,195
22,527
-66,268
Investing Cash Flow
185,007
185,007
71,840
-461,336
-294,144
Financing Cash Flow
7,736
7,736
276,448
111,590
756,141
End Cash Position
290,111
290,111
444,614
245,521
572,740
Interest Paid Supplemental Data
32
32
160
376
567
Capital Expenditure
-8,946
-8,946
-33,732
-48,951
-46,811
Issuance of Capital Stock
--
--
270,168
108,258
757,449
Repayment of Debt
-485
-485
-2,252
-2,287
-2,118
Free Cash Flow
-356,192
-356,192
-182,927
-26,424
-113,079
12/31/2021 - 2/16/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASPHF Ascentage Pharma Group International
5.83
-9.69%
T3X.F Telix Pharmaceuticals Limited
16.89
+6.93%
AAPG Ascentage Pharma Group Internat
25.50
+6.69%
MBX MBX Biosciences, Inc.
9.27
+3.11%
BCAX Bicara Therapeutics Inc.
15.63
+0.77%
MTNB Matinas BioPharma Holdings, Inc.
0.5950
+1.71%
KYTX Kyverna Therapeutics, Inc.
2.1400
+0.47%
PRTA Prothena Corporation plc
9.65
+0.63%
DYN Dyne Therapeutics, Inc.
11.11
+3.06%
TVTX Travere Therapeutics, Inc.
17.63
+5.57%